Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Walker H. Colston | M | 63 | 21 years | |
| Chris Williams | M | 62 | 16 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Victor Alston | M | 52 | 8 years | |
| Alfred Mann | M | 98 | 18 years | |
| Atul Bhatnagar | M | 66 | 5 years | |
| Matthew Pfeffer | M | 67 | - | |
| Jonathan McGuire | M | 61 | - | |
| Anne-Marie Ripley | F | 54 | 11 years | |
| Maik Lankau | M | - | - | |
| Laurent Asscher | M | 53 | 9 years | |
| Gail Hamilton | F | 74 | 12 years | |
| Jonathan Fram | M | 66 | 12 years | |
| Stephen Okland | M | 60 | - | |
| Jon F. Rager | M | 84 | 16 years | |
| Tim Jones | M | - | - | |
| Jim R. Smith | M | - | - | |
| Brent Novak | M | 51 | 14 years | |
| Brian V. Mech | M | 55 | 16 years | |
| Patti Key | F | - | - | |
| Anupam Sahai | M | - | - | |
| Raymond de Graaf | M | 57 | 7 years | |
| James Miller | M | - | - | |
| Bob Holmen | M | 60 |
CoCensys, Inc.
 CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 2 years |
| Alan Grahame | M | 71 | 8 years | |
| Doug Samuelson | M | 64 | 4 years | |
| John Moses | M | 65 | 1 years | |
| Cliff Hannel | M | 61 | - | |
| David Edward Anderson | M | 68 | 6 years | |
| Robert W. Bass | M | 77 | 7 years | |
| Lowell E. Sears | M | 73 |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 4 years |
| Alexander Pepe | M | 61 | - | |
| Massoud Entekhabi | M | 70 | - | |
| Alan Cuellar Amrod | M | 65 | - | |
| David Jacques | M | 61 | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 34 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Thomas Miller
- Personal Network
